Novo Nordisk board members step down after clash with controlling shareholder
1. Novo Nordisk board members will step down after a disagreement. 2. A lack of consensus on board composition with controlling shareholder exists. 3. Stock traded 1.2% lower amid leadership changes. 4. Extraordinary General Meeting set for Nov. 14 to address board issues. 5. Chair Helge Lund and other directors will not seek re-election.